Listen Now

The inefficiencies of qualitative image analysis in clinical trials In this episode of Quibim Blog, CEO and founder Angel Alberich-Bayarri sits down with Dan Sfera and discusses the differences between quantitative and qualitative imaging analysis when it comes to clinical research. Some of the more common therapeutic indications that involve image analysis include: oncology, central nervous system disorder, and respiratory illnesses. Angel made a great analogy in this interview of artificial intelligence, the algorithms that power Quibim's quantitative imaging capabilities, being similar to GPS when it comes to assisting drivers in navigating during their commutes. Algorithms in imaging analysis are similar in the sense that they are tools to assist the imaging analysis readers (radiologists) in making quantitative diagnosis' rather that the current industry standard of qualitative assessments. That seems to be the key benefit of Quibim's value proposition: taking a subjective diagnosis and adding a quantitative component to it in order to allow the clinicians to make better informed decisions. http://www.quibimblog.com

Quibim Blog Episode 2 Quibim's Chief Technology Officer, Rafael Hernández, sits down to explain how he got started with Quibim, the importance of biomarkers in clinical research, and some of the technology behind Quibim's service offerings. The key takeaway from me was the differentiation between the algorithms used to analyze the biomarker images, and the customizable software utilized to interface with the images. Another point of interest is the storing capabilities of the images on a HIPAA compliant cloud server, or, on an equally secure local server at the location of the particular client, for example, a local hospital. Finally, patient-centricity is at the root of these innovations. Quibim's technology allows for encrypted and completely de identified biomarker images that allow the Sponsors to analyze results without compromising the privacy of the individual patients. Furthermore, by pioneering breakthrough diagnostic services, Quibim is contributing directly to medical advances and breakthroughs that we can all benefit from in the near future! http://www.quibim.com http://www.quibimblog.com

Dan Sfera and Irene Mayorga discuss clinical research biomarker and image analysis when it comes to searching for clinical trial breakthroughs. http://www.quibimblog.com